2025-05-13-PitchBook-PitchBook年一季度Agtech公共资产负债表和估值指南（英）_9页_470kb

报告摘要

Q1 2025 Agtech Public Comp Sheet and Valuation Guide Summary

Overview

This report analyzes theQ1 2025 public market performance, revenue trends, valuation metrics, EBITDA margins, and subsector comparisons for global agricultural technology companies. It highlights key challenges, growth outlooks, and profitabilities across different agricultural technology segments.

Key Takeaways

Market Performance: Public markets faced challenges in Q1 2025, with the S&P 500 declining by 5% and Nasdaq falling 10%. Agtech stock activity varied significantly across segments.
Stock Returns: Plant biotech incumbents saw median stock price increases of 10%. Indoor farming solutions experienced a significant decline, with median stock prices plummeting by 47%.
Revenue Growth: Agtech contracted by 5% in 2024. Growth is projected to recover to 2% in 2025, but remains vulnerable to U.S. import policies.
EBITDA Margins: The median EBITDA margin for the agtech sector remains estimated at 16% in 2025. Animal agriculture outperforms with projected expansion to 28%.
Valuation: Public Agtech valuations, measured by EV/revenue and EV/EBITDA, vary significantly by subsector.

Performance Highlights

S&P 500: Down 5%
Nasdaq: Down 10%
Plant Biotech Incumbents: Stock increase of 10% (median)
Indoor Farming: -47% stock decline (median)
Animal Agriculture: 23% to 28% EBITDA margin growth

Valuation

EV/LTM Revenue: $12x to $30+x across sectors
EV/LTM EBITDA: $10x to $25+2x across sectors
Market Cap Effects: Significant differences between biotech fast-growers and medium-growth / established incumbents